A detailed history of Montag A & Associates Inc transactions in Moderna, Inc. stock. As of the latest transaction made, Montag A & Associates Inc holds 1,286 shares of MRNA stock, worth $81,223. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,286
Previous 1,386 7.22%
Holding current value
$81,223
Previous $147,000 3.4%
% of portfolio
0.01%
Previous 0.01%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 31, 2024

SELL
$101.21 - $166.61 $10,121 - $16,661
-100 Reduced 7.22%
1,286 $152,000
Q1 2024

May 07, 2024

SELL
$85.37 - $115.44 $3,500 - $4,733
-41 Reduced 2.87%
1,386 $147,000
Q4 2023

Feb 07, 2024

SELL
$69.51 - $104.43 $60,126 - $90,331
-865 Reduced 37.74%
1,427 $141,000
Q3 2023

Nov 09, 2023

SELL
$96.41 - $126.61 $38,564 - $50,644
-400 Reduced 14.86%
2,292 $236,000
Q2 2023

Aug 09, 2023

SELL
$118.5 - $160.53 $325,519 - $440,975
-2,747 Reduced 50.51%
2,692 $327,000
Q1 2023

May 11, 2023

BUY
$135.66 - $197.02 $43,818 - $63,637
323 Added 6.31%
5,439 $835,000
Q4 2022

Feb 02, 2023

BUY
$118.38 - $210.04 $392,429 - $696,282
3,315 Added 184.06%
5,116 $918,000
Q3 2022

Nov 09, 2022

SELL
$118.07 - $194.18 $153,372 - $252,239
-1,299 Reduced 41.9%
1,801 $213,000
Q2 2022

Aug 10, 2022

SELL
$117.13 - $176.59 $803,043 - $1.21 Million
-6,856 Reduced 68.86%
3,100 $443,000
Q1 2022

May 02, 2022

SELL
$126.46 - $235.05 $19,474 - $36,197
-154 Reduced 1.52%
9,956 $1.72 Million
Q4 2021

Feb 09, 2022

SELL
$225.82 - $368.51 $1.01 Million - $1.65 Million
-4,489 Reduced 30.75%
10,110 $2.57 Million
Q3 2021

Nov 08, 2021

SELL
$221.9 - $484.47 $1.37 Million - $3 Million
-6,190 Reduced 29.78%
14,599 $5.62 Million
Q2 2021

Aug 03, 2021

BUY
$129.91 - $234.98 $99,121 - $179,289
763 Added 3.81%
20,789 $4.89 Million
Q1 2021

May 14, 2021

BUY
$109.18 - $185.98 $2.02 Million - $3.45 Million
18,526 Added 1235.07%
20,026 $2.62 Million
Q4 2020

Feb 12, 2021

BUY
$65.74 - $169.86 $98,609 - $254,790
1,500 New
1,500 $157,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $24.7B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Montag A & Associates Inc Portfolio

Follow Montag A & Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Montag A & Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Montag A & Associates Inc with notifications on news.